Fell Donald G. 4/A
4/A · Aspire Biopharma Holdings, Inc. · Filed Jun 10, 2025
Insider Transaction Report
Form 4/AAmended
Fell Donald G.
Director
Transactions
- Purchase
Common Stock, par value $0.0001
2025-06-04$0.39/sh+9,500$3,705→ 9,500 total - Purchase
Common Stock, par value $0.0001
2025-06-05$0.39/sh+10,500$4,095→ 20,000 total